Dr. Kate Moore has been with Nuventra for 3+ years and has clinical pharmacology and PK experience in all clinical stages of development, with specific interest in DMPK and drug-drug interactions (DDIs). Kate has been actively involved with several noncompartmental and population PK analyses & has supported the development of many clinical pharmacology plans and gap analyses. Kate also has extensive program management experience where she has managed several projects throughout the entire development spectrum, from pre-IND, to first in human, to post-marketing studies; tracking budgets, deliverables, timelines, and necessary communications. Kate also brings clinical operations experience to the team and was the study program manager for a Phase 4 clinical trial. Kate has recently taken on the position of associate director of program management where she has primarily served as internal management, overseeing the program management group and supporting the development of Nuventra’s core processes.